N@N

Eurand N.V.: Eurand to Present at Barclays Capital Global Healthcare Conference

^{Published on 2009-02-26 09:20:14, Last Modified on 2009-02-26 09:20:49 - Market Wire}
 

PHILADELPHIA, PA--(Marketwire - February 26, 2009) - Eurand N.V. (NASDAQ: [ EURX ]), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced today that it is scheduled to present at the upcoming Barclays Capital Global Healthcare Conference. Gearóid Faherty, Eurand's Chairman and Chief Executive Officer, will be presenting.

 Event: Barclays Capital Global Healthcare Conference Date: Tuesday, March 10, 2009 Time: 2:30 p.m. ET Location: Loews Miami Beach Hotel 

An audio webcast of the presentation will be available by accessing the investor relations section of Eurand's web site at [ www.eurand.com ]. A replay of the presentation will be available until March 17, 2009.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. Eurand has had four products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking orally disintegrating tablet (ODT) formulations, and drug conjugation.

Eurand is a global company with facilities in the U.S. and Europe. For more information, visit Eurand's website at [ www.eurand.com ].